1. Home
  2. RANI vs DEVS Comparison

RANI vs DEVS Comparison

Compare RANI & DEVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • DEVS
  • Stock Information
  • Founded
  • RANI 2012
  • DEVS N/A
  • Country
  • RANI United States
  • DEVS Canada
  • Employees
  • RANI N/A
  • DEVS N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • DEVS
  • Sector
  • RANI Health Care
  • DEVS
  • Exchange
  • RANI Nasdaq
  • DEVS NYSE
  • Market Cap
  • RANI 17.0M
  • DEVS 14.6M
  • IPO Year
  • RANI 2021
  • DEVS N/A
  • Fundamental
  • Price
  • RANI $0.54
  • DEVS $0.36
  • Analyst Decision
  • RANI Strong Buy
  • DEVS
  • Analyst Count
  • RANI 4
  • DEVS 0
  • Target Price
  • RANI $7.75
  • DEVS N/A
  • AVG Volume (30 Days)
  • RANI 323.8K
  • DEVS 1.0M
  • Earning Date
  • RANI 08-05-2025
  • DEVS 07-15-2025
  • Dividend Yield
  • RANI N/A
  • DEVS N/A
  • EPS Growth
  • RANI N/A
  • DEVS N/A
  • EPS
  • RANI N/A
  • DEVS N/A
  • Revenue
  • RANI $1,200,000.00
  • DEVS $10,164.00
  • Revenue This Year
  • RANI N/A
  • DEVS N/A
  • Revenue Next Year
  • RANI N/A
  • DEVS N/A
  • P/E Ratio
  • RANI N/A
  • DEVS N/A
  • Revenue Growth
  • RANI N/A
  • DEVS N/A
  • 52 Week Low
  • RANI $0.46
  • DEVS $0.18
  • 52 Week High
  • RANI $4.19
  • DEVS $3.00
  • Technical
  • Relative Strength Index (RSI)
  • RANI 42.19
  • DEVS N/A
  • Support Level
  • RANI $0.50
  • DEVS N/A
  • Resistance Level
  • RANI $0.60
  • DEVS N/A
  • Average True Range (ATR)
  • RANI 0.03
  • DEVS 0.00
  • MACD
  • RANI 0.02
  • DEVS 0.00
  • Stochastic Oscillator
  • RANI 42.04
  • DEVS 0.00

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About DEVS DEVVSTREAM CORP

DevvStream Corp is a technology-based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve its sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.

Share on Social Networks: